Shares of Azenta (NASDAQ:AZTA) surged 4.2% following news that the White House plans to propose a two-year extension of Obamacare subsidies, benefiting insurers and consumers. The market views this news as meaningful but not fundamentally changing its perception of Azenta, a life sciences company with recent positive revenue and profitability results. Azenta’s revenue grew 5.5% year on year, beating Wall Street estimates, and its operating margin improved. Despite being down 26.7% year-to-date, investors remain optimistic about Azenta’s operational performance. Learn more about Azenta and its potential growth opportunities.

Read more at StockStory: Why Azenta (AZTA) Stock Is Trading Up Today